Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Imunon Inc IMNN

Healthcare Biotechnology
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:IMNN)

IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting

GlobeNewswire November 7, 2024

IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire November 7, 2024

IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024

GlobeNewswire October 31, 2024

IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting

GlobeNewswire October 30, 2024

IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire October 7, 2024

UPDATE - IMUNON's Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management

GlobeNewswire September 9, 2024

IMUNON's Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management

GlobeNewswire September 9, 2024

IMUNON to Host R&D Day on September 18th

GlobeNewswire August 28, 2024

IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire August 14, 2024
View More News ››

Opinion & Analysis (NDAQ:IMNN)

BTIG's Hartaj Singh's advice for biotech investors: 'hold your powder' 'til winter

Gail Dutton October 1, 2015
View More Opinion ››

Bullboard Posts (NDAQ:IMNN)

IMNN: A Promising DNA-Based Immunotherapy and Vaccine Platfo

http://beyondspx.com/2024/08/01/imnn-a-promising-dna-based-immunotherapy-and-vaccine-platform/
MikeTester - August 1, 2024

IMNN....$75 mil Shelf on file EDGAR

Don't get greedy is my advice ; ) ......currently at $3.60 in PM trading. Cheers ! Here is the EDGAR S3 filing: sec.gov/Archives...
Iseneschal - July 30, 2024

Make or break time?

at $1.88
Iseneschal - March 4, 2021

CLSN - On the Move Today

Intraday high of $2.663 , up 11.42 %. Accumulation on good volume./ok2
ok2buy - December 7, 2017

yahoo

wow!
cdogou812 - October 3, 2017

huge news this is big UMB

The expansion plan includes two buildings and four phases of construction. The first phase is a building envelope of 130,000 sq ft. ...
wintersky - July 6, 2017
View more Bullboard ››

Grid Battery Metals Inc.

Grid Battery Metals Inc.

Grid Battery Metals Inc. is a Canada-based exploration company. The Company focuses on exploration for high-value battery ...
View More »